DÄ internationalArchiveReferences


The Medical and Surgical Treatment of Glaucoma

Dtsch Arztebl Int 2009; 106(37): 597-606. DOI: 10.3238/arztebl.2009.0597

Dietlein, T S; Hermann, M M; Jordan, J F

1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M: Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268–79. MEDLINE
2. Brandt JD, Beiser JA, Kass MA, Gordon MO: Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001; 108: 1779–88. MEDLINE
3. Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC, Barbados Eye Studies Group: Incident open-angle glaucoma and intraocular pressure. Ophthalmology 2007; 114: 1810–5. MEDLINE
4. Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487–97. MEDLINE
5. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. 2000; Am J Ophthalmol 130: 429–40. MEDLINE
6. Collaborative Normal-Tension Glaucoma Study Group: Natural history of normal-tension glaucoma. Ophthalmology 2001; 108: 247–53. MEDLINE
7. Collaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498–505. MEDLINE
8. European Glaucoma Society: Terminologie und Handlungsrichtlinien für die Glaukome. 3.rd ed. (2008), DOGMA, Savona, Italien (www.eugs.org)
9. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121: 48–56. MEDLINE
10. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP; CIGTS Study Group: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108: 1943–53. MEDLINE
11. van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH: Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005; 112: 1177–85. MEDLINE
12. Pfeiffer N, Grierson I, Goldsmith H, Appleton P, Hochgesand D, Winkgen A: Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study). Arch Ophthalmol 2003; 121: 23–31. MEDLINE
13. Musch DC, Gillespie BW, Niziol LM, Cashwell LF, Lichter PR: Factors associated with intraocular pressure before and during 9 years of treatment in the collaborative initial glaucoma treatment study. Ophthalmology 2008; 115: 927–33. MEDLINE
14. Alwitry A, Patel V, King AW: Fornix vs. limbal based trabeculectomy with mitomycin C. Eye 2005; 19: 631–5. MEDLINE
15. Casson R, Rahman R, Salmon JF: Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85: 686–8. MEDLINE
16. Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL: Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol 2007; 143: 9-22. MEDLINE
17. Solomon A, Ticho U, Frucht-Perry J: Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. J Ocul Pharmacol Ther 1999; 15: 283–93. MEDLINE
18. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC: Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002; 120: 297–300. MEDLINE
19. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr: Endophthalmitis after filtering surgery with mitomycin C. Arch Ophthalmol 1996; 114: 943–9. MEDLINE
20. Stein JD, Ruiz Jr D, Belsky D, Lee PP, Sloan FA: Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology 2008; 115: 1109–16. MEDLINE
21. Al-Torbak AA, Al-Shahwan S, Al-Jadaan I, Al-Hommadi A, Edward DP: Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol 2005; 89: 454–8. MEDLINE
22. Grehn F: The value of trabeculotomy in glaucoma surgery. Curr Opin Ophthalmol 1995; 6: 52–66. MEDLINE
23. Dietlein TS, Jacobi PC, Krieglstein GK: Prognosis of primary ab externo surgery for primary congenital glaucoma. Br J Ophthalmol 1999; 83: 317–22. MEDLINE
24. Nagar M, Ogunyomade A, O`Brart DPS, Howes F, Marshall J: A randomized, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open-angle glaucoma. Br J Ophthalmol 2005; 89: 1413–7. MEDLINE
25. Congdon NG, Friedman DS: Angle-closure glaucoma: impact, etiology, diagnosis, and treatment. Curr Opin Ophthalmol 2003; 14: 70–3. MEDLINE
e1. World Health Organization: Prevention of Blindness and Visual Impairment. http://www.who.int/blindness/causes/priority/en/index7.html
e2. Michelson G: Epidemiologie, Screening, Ökonomie. In: Krieglstein GK (ed.): Glaukom 2006. Eine Konsensus-Konferenz, Springer-Verlag, Heidelberg 2007.
e3. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S: Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma and normal-tension glaucoma. Jpn J Ophthalmol 2004; 48: 380–5. MEDLINE
e4. Dietlein TS: Normaldruckglaukom – ein praxisorientierter Überblick. KIin Monatsbl Augenheilkd 2009; 226: R75–84.
e5. Leitlinien BVA/DOG: Leitlinie 15a/c, Primär chronisches Offenwinkelglaukom, Normaldruckglaukom und okuläre Hypertension. www.augeninfo.de/leit/index.htm
e6. Michelson G, Hornegger J, Wärntges S, Lausen B: The papilla as screening parameter for early diagnosis of glaucoma [Die Papille als Screening-Parameter für die Früherkennung des Glaukoms]. Dtsch Arztebl Int 2008; 105(34–35): 583–9. MEDLINE
e7. Sycha T, Vass C, Findl O, Bauer P, Groke I, Schmettere L, Eichler HG: Intervention for normal tension glaucoma. Cochrane Database Syst Rev 2003; Issue 1. Art.No. CD 002222. MEDLINE
e8. Hedman K, Watson PG, Alm A: The effect of latanoprost on intraocular pressure during 2 years of treatment. Surv Ophthalmol 2002; 47 (Suppl 1): 65–76. MEDLINE
e9. Law SK, Kim E, Yu F, Caprioli J: Clinical cystoid macular edema after cataract surgery in glaucoma patients. J Glaucoma 2009 (epub ahead of print). MEDLINE
e10. Tomita G, Niwa Y, Shinohara H, Hayashi N, Yamamoto T, Kitazawa Y: Changes in optic nerve head blood flow and retrobular hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int Ophthalmol 1999; 23: 3–10. MEDLINE
e11. Gugleta K, Orgul S, Stumpfig D, Dubler B, Flammer J: Fludrocortisone in the treatment of systemic hypotension in primary open-angle glaucoma patients. Int Ophthalmol 1999; 23: 25–30. MEDLINE
e12. Law SK, Li T: Acupuncture for glaucoma. Cochrane Database Syst Rev 2007, Issue 4. Art.No. 006030. MEDLINE
e13. Burr J, Azuara-Blanco A, Avenell A: Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2004, Issue 2. Art.No. CD004399. MEDLINE
e14. Wilkins M, Indar A, Wormald R: Intra-operative Mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2005, Issue 4. Art.No. CD002897. MEDLINE
e15. Wormald R, Wilkins M, Bunce C: Postoperative 5-Fluorouracil for glaucoma surgery. Cochrane Database Syst Rev 2001, Issue 3. Art.No. 001132. MEDLINE
e16. Minckler D, Vedula SS, Li T, Mathew M, Ayyala R, Francis B: Aqueous shunts for glaucoma. Cochrane Database Syst Rev 2006, Issue 2. Art.No. 004918. MEDLINE
e17. Krott R, Diestelhorst M, Zollweg M, Krieglstein GK: Dose response relationship of transscleral contact cyclophotocoagulation. Ophthalmologe 1997; 94: 273–6. MEDLINE
e18. Becker M, Funk J: Diode laser cyclophotocoagulation as the primary surgical intervention in glaucoma. Ophthalmologe 2001; 98: 1145–8. MEDLINE
e19. Rolim de Moura C, Paranhos A Jr, Wormald R: Laser trabeculoplasty for open-angle glaucoma. Cochrane Database Syst Rev 2007; Issue 4. Art.No.: CD 003919. MEDLINE
e20. McIlraith I, Strasfeld M, Colev G, Hutnik CM: Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 2006; 15: 124–30. MEDLINE
e21. Best UP, Domack H, Schmidt V: Langzeitergebnisse nach selektive Lasertrabekuloplastik – eine klinische Studie an 269 Augen. Klin Monatsbl Augenheilkd 2005; 222: 326–31. MEDLINE
e22. Lewis RA, von Wolff K, Tetz M, Korber N, Kearney JR, Shingleton B, Samuelson TW.: Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg 2007; 33: 1217–26. MEDLINE
e23. Detry-Morel M, Pourjavan S, Detry MB: Comparative safety profile between „modern“ trabeculectomy and non-penetrating deep sclerectomy. Bull Soc Belge Ophthalmol 2006; 300: 43–54. MEDLINE
e24. Gray TA, Orton LC, Henson D, Harper R, Waterman H: Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev 2009, Issue 2, Art.No. CD 006132. MEDLINE